GSK Investigational Site

Fairfield, Connecticut 06824

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer's Disease, Epilepsy, Partial, Migraine Disorders, Multiple Sclerosis, Neoplasms, Breast, Restless Legs Syndrome

Studies at this site

• Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis — Completed
• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents — Completed
• A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) — Completed
• Migraine Study in Adolescent Patients — Completed
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy — Completed
• A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) — Completed
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed